Back to mobile site

BMO Capital Starts Q32 Bio Inc. (QTTB) at Outperform

December 5, 2024 4:10 PM EST Send to a Friend
BMO Capital analyst Etzer Darout initiates coverage on Q32 Bio Inc. (NASDAQ: QTTB) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login